Dolichyldiphosphatase

Quick info Localization Expansion Sequence features Structure Function Putative motif mimicry Homologs Download

Quick info

Protein:

Gene product:

PAP2 superfamily, putative

Species:

Leishmania major

UniProt:

Q4QBA9_LEIMA

TriTrypDb:

LmjF.23.1665 , LMJLV39_230013400 , LMJSD75_230013700

Length:

236

Localization

Secreted promastigote


Source	Evidence on protein	Close homologs
Cuervo et al.	no	yes: 0
Hassani et al.	no	yes: 0
Forrest at al. (metacyclic)	no	yes: 0
Forrest at al. (procyclic)	no	yes: 0
Silverman et al.	no	yes: 0
Pissara et al.	no	yes: 0

Secreted amastigote


Source	Evidence on protein	Close homologs
Pires et al.	no	yes: 0

Exosome


Source	Evidence on protein	Close homologs
Silverman et al.	no	yes: 0

Glycosome


Source	Evidence on protein	Close homologs
Jamdhade et al.	no	yes: 0

Predictions


Source	Evidence on protein	Close homologs
DeepLoc
SignalP6	no	yes: 0, no: 7
NetGPI	no	yes: 0, no: 7

Cellular components
Term	Name	Level	Count
GO:0043226	organelle	2	2
GO:0043227	membrane-bounded organelle	3	2
GO:0043229	intracellular organelle	3	2
GO:0043231	intracellular membrane-bounded organelle	4	2
GO:0110165	cellular anatomical entity	1	5
GO:0016020	membrane	2	3

Expansion

Sequence features

Q4QBA9

Sequence

MSA

Disorder

Secondary

Topology

Domains

SignalP

GPI

Phosphorylations

ELMs

Structure

Predicted structure by AlphaFold2

Related structures:

AlphaFold database: Q4QBA9

Function

Biological processes
Term	Name	Level	Count
GO:0006486	protein glycosylation	4	5
GO:0006487	protein N-linked glycosylation	5	5
GO:0006629	lipid metabolic process	3	2
GO:0006807	nitrogen compound metabolic process	2	5
GO:0008152	metabolic process	1	5
GO:0008610	lipid biosynthetic process	4	2
GO:0009058	biosynthetic process	2	2
GO:0019538	protein metabolic process	3	5
GO:0036211	protein modification process	4	5
GO:0043170	macromolecule metabolic process	3	5
GO:0043412	macromolecule modification	4	5
GO:0043413	macromolecule glycosylation	3	5
GO:0044238	primary metabolic process	2	5
GO:0070085	glycosylation	2	5
GO:0071704	organic substance metabolic process	2	5
GO:1901564	organonitrogen compound metabolic process	3	5
GO:1901576	organic substance biosynthetic process	3	2

Molecular functions
Term	Name	Level	Count
GO:0003824	catalytic activity	1	5
GO:0016462	pyrophosphatase activity	5	5
GO:0016787	hydrolase activity	2	5
GO:0016817	hydrolase activity, acting on acid anhydrides	3	5
GO:0016818	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	4	5
GO:0047874	dolichyldiphosphatase activity	6	5

Putative motif mimicry


Leishmania	From	To	Domain/Motif	Score
CLV_PCSK_KEX2_1	57	59	PF00082	0.374
CLV_PCSK_PC1ET2_1	57	59	PF00082	0.374
CLV_PCSK_SKI1_1	193	197	PF00082	0.542
CLV_PCSK_SKI1_1	54	58	PF00082	0.313
DEG_Nend_Nbox_1	1	3	PF02207	0.615
DOC_CKS1_1	112	117	PF01111	0.304
DOC_MAPK_MEF2A_6	126	134	PF00069	0.291
DOC_PP2B_LxvP_1	120	123	PF13499	0.272
DOC_PP2B_LxvP_1	188	191	PF13499	0.395
DOC_PP4_FxxP_1	112	115	PF00568	0.300
DOC_USP7_MATH_1	116	120	PF00917	0.393
DOC_USP7_MATH_1	171	175	PF00917	0.328
DOC_USP7_MATH_1	207	211	PF00917	0.401
DOC_USP7_MATH_1	221	225	PF00917	0.656
DOC_USP7_MATH_1	50	54	PF00917	0.401
DOC_USP7_UBL2_3	229	233	PF12436	0.691
DOC_USP7_UBL2_3	57	61	PF12436	0.583
DOC_WW_Pin1_4	111	116	PF00397	0.378
DOC_WW_Pin1_4	69	74	PF00397	0.520
LIG_14-3-3_CanoR_1	219	228	PF00244	0.644
LIG_14-3-3_CanoR_1	96	104	PF00244	0.359
LIG_Actin_WH2_2	127	145	PF00022	0.313
LIG_Actin_WH2_2	41	59	PF00022	0.328
LIG_BRCT_BRCA1_1	81	85	PF00533	0.357
LIG_FHA_1	112	118	PF00498	0.253
LIG_FHA_1	161	167	PF00498	0.313
LIG_FHA_1	34	40	PF00498	0.332
LIG_FHA_1	47	53	PF00498	0.408
LIG_FHA_1	88	94	PF00498	0.389
LIG_FHA_1	99	105	PF00498	0.319
LIG_GBD_Chelix_1	151	159	PF00786	0.210
LIG_LIR_Apic_2	110	115	PF02991	0.359
LIG_LIR_Gen_1	136	145	PF02991	0.226
LIG_LIR_Gen_1	82	93	PF02991	0.308
LIG_LIR_Nem_3	136	141	PF02991	0.226
LIG_LIR_Nem_3	82	88	PF02991	0.360
LIG_SH2_CRK	138	142	PF00017	0.226
LIG_SH2_SRC	32	35	PF00017	0.338
LIG_SH2_STAP1	135	139	PF00017	0.351
LIG_SH2_STAT3	28	31	PF00017	0.443
LIG_SH2_STAT3	92	95	PF00017	0.357
LIG_SH2_STAT5	158	161	PF00017	0.357
LIG_SH2_STAT5	176	179	PF00017	0.389
LIG_SH2_STAT5	28	31	PF00017	0.323
LIG_SH2_STAT5	32	35	PF00017	0.376
LIG_SH2_STAT5	9	12	PF00017	0.557
LIG_SH2_STAT5	92	95	PF00017	0.365
LIG_SH3_1	70	76	PF00018	0.500
LIG_SH3_3	112	118	PF00018	0.300
LIG_SH3_3	34	40	PF00018	0.257
LIG_SH3_3	60	66	PF00018	0.544
LIG_SH3_3	70	76	PF00018	0.461
LIG_SUMO_SIM_anti_2	192	198	PF11976	0.334
LIG_SUMO_SIM_anti_2	20	26	PF11976	0.328
LIG_SUMO_SIM_anti_2	84	90	PF11976	0.313
LIG_SUMO_SIM_par_1	130	136	PF11976	0.351
LIG_SUMO_SIM_par_1	162	168	PF11976	0.415
LIG_WRC_WIRS_1	198	203	PF05994	0.226
LIG_WW_2	115	118	PF00397	0.272
MOD_CK1_1	17	23	PF00069	0.261
MOD_CK1_1	174	180	PF00069	0.394
MOD_CK1_1	215	221	PF00069	0.608
MOD_CK1_1	84	90	PF00069	0.373
MOD_GlcNHglycan	173	176	PF01048	0.605
MOD_GlcNHglycan	19	22	PF01048	0.274
MOD_GlcNHglycan	203	206	PF01048	0.412
MOD_GlcNHglycan	223	226	PF01048	0.486
MOD_GSK3_1	107	114	PF00069	0.324
MOD_GSK3_1	133	140	PF00069	0.357
MOD_GSK3_1	197	204	PF00069	0.409
MOD_GSK3_1	46	53	PF00069	0.336
MOD_GSK3_1	74	81	PF00069	0.505
MOD_N-GLC_1	107	112	PF02516	0.504
MOD_N-GLC_1	14	19	PF02516	0.265
MOD_N-GLC_1	171	176	PF02516	0.562
MOD_NEK2_1	1	6	PF00069	0.607
MOD_NEK2_1	160	165	PF00069	0.330
MOD_NEK2_1	197	202	PF00069	0.419
MOD_NEK2_2	107	112	PF00069	0.353
MOD_NEK2_2	133	138	PF00069	0.357
MOD_PKA_2	212	218	PF00069	0.583
MOD_Plk_1	107	113	PF00069	0.304
MOD_Plk_1	14	20	PF00069	0.265
MOD_Plk_4	107	113	PF00069	0.322
MOD_Plk_4	133	139	PF00069	0.439
MOD_Plk_4	33	39	PF00069	0.314
MOD_Plk_4	81	87	PF00069	0.387
MOD_ProDKin_1	111	117	PF00069	0.378
MOD_ProDKin_1	69	75	PF00069	0.520
TRG_DiLeu_BaEn_1	192	197	PF01217	0.321
TRG_ENDOCYTIC_2	138	141	PF00928	0.226
TRG_Pf-PMV_PEXEL_1	58	62	PF00026	0.391

Homologs


Protein	Taxonomy	Sequence identity	Coverage
A0A0N1I7E3	Leptomonas seymouri	48%	100%
A0A0S4JMP4	Bodo saltans	30%	94%
A0A3S7WXN1	Leishmania donovani	95%	100%
A4HCT0	Leishmania braziliensis	75%	98%
A4I0A4	Leishmania infantum	95%	100%
E9AW69	Leishmania mexicana (strain MHOM/GT/2001/U1103)	88%	99%